CD73: Friend or Foe in Lung Injury
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065545 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Xiu-Min Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Acupuncture and Tuina, Chengdu University of Traditional Medicine, Chengdu 610075, China. Hauptthemen laut MEDLINE: Lung Injury, Lung Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan, Postdoctoral Science Foundation of China.
Abstract (Originalsprache)
Ecto-5′-nucleotidase (CD73) plays a strategic role in calibrating the magnitude and chemical nature of purinergic signals that are delivered to immune cells. Its primary function is to convert extracellular ATP to adenosine in concert with ectonucleoside triphosphate diphosphohydrolase-1 (CD39) in normal tissues to limit an excessive immune response in many pathophysiological events, such as lung injury induced by a variety of contributing factors. Multiple lines of evidence suggest that the location of CD73, in proximity to adenosine receptor subtypes, indirectly determines its positive or negative effect in a variety of organs and tissues and that its action is affected by the transfer of nucleoside to subtype-specific adenosine receptors. Nonetheless, the bidirectional nature of CD73 as an emerging immune checkpoint in the pathogenesis of lung injury is still unknown. In this review, we explore the relationship between CD73 and the onset and progression of lung injury, highlighting the potential value of this molecule as a drug target for the treatment of pulmonary disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Acupuncture and Tuina, Chengdu University of Traditional Medicine, Chengdu 610075, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan
- Postdoctoral Science Foundation of China
- National Key R&D Program of China
Zitieren
APA
Hu, X. M., Shi, N. R., Zhang, J. Z., Zuo, Y. Q., Wang, X., Zhao, Y. F., & Wu, J. S. (2023). CD73: Friend or Foe in Lung Injury. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065545
Vancouver
Hu XM, Shi NR, Zhang JZ, Zuo YQ, Wang X, Zhao YF, et al. CD73: Friend or Foe in Lung Injury. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065545
BibTeX
@article{Hu2023,
author = {Hu, Xiu-Min and Shi, Nan-Rui and Zhang, Ji-Zhou and Zuo, Yan-Qin and Wang, Xin and Zhao, Ya-Fei and Wu, Jia-Si},
title = {CD73: Friend or Foe in Lung Injury},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065545}
}
EUVIMED